Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

SHA:603520 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,551	3,810	4,823	6,694	15,886	16,099
Market Cap Growth	19.31%	-21.00%	-27.95%	-57.86%	-1.32%	125.95%
Enterprise Value	6,914	5,711	7,239	8,716	17,059	17,207
Last Close Price	10.38	8.57	13.80	18.95	44.43	44.70
PE Ratio	-	-	109.03	-	49.07	67.44
Forward PE	61.06	17.38	23.53	23.90	37.04	45.75
PS Ratio	1.90	1.62	2.20	3.14	7.94	11.78
PB Ratio	1.75	1.45	2.74	3.78	7.17	8.63
P/TBV Ratio	2.39	1.98	4.66	6.38	11.16	14.56
P/FCF Ratio	-	-	-	-	77.51	755.35
P/OCF Ratio	13.55	19.69	108.25	-	31.22	92.27
EV/Sales Ratio	2.89	2.43	3.30	4.09	8.53	12.59
EV/EBITDA Ratio	22.21	20.27	21.86	29.25	28.69	36.36
EV/EBIT Ratio	113.12	90.98	47.76	62.64	38.67	49.58
EV/FCF Ratio	-446.75	-	-	-	83.23	807.36
Debt / Equity Ratio	1.00	0.99	1.74	1.57	0.86	0.98
Debt / EBITDA Ratio	8.40	9.23	9.23	9.29	3.20	3.85
Debt / FCF Ratio	-	-	-	-	9.31	85.44
Asset Turnover	0.41	0.41	0.41	0.42	0.43	0.35
Inventory Turnover	1.78	1.70	1.79	2.59	2.38	1.60
Quick Ratio	0.36	0.39	0.36	0.50	0.81	0.89
Current Ratio	0.89	0.83	0.77	0.79	1.09	1.27
Return on Equity (ROE)	-1.10%	-2.23%	2.52%	-3.61%	16.17%	17.53%
Return on Assets (ROA)	0.65%	0.68%	1.75%	1.71%	5.93%	5.50%
Return on Invested Capital (ROIC)	1.25%	1.41%	3.66%	3.88%	12.20%	10.67%
Return on Capital Employed (ROCE)	1.70%	1.90%	5.90%	5.50%	14.70%	12.00%
Earnings Yield	-0.64%	-1.29%	0.92%	-1.13%	2.04%	1.48%
FCF Yield	-0.34%	-7.54%	-4.60%	-8.22%	1.29%	0.13%
Dividend Yield	1.93%	1.75%	-	2.64%	0.80%	0.80%
Payout Ratio	-	-	442.32%	-	62.08%	62.42%
Buyback Yield / Dilution	6.69%	-20.25%	1.31%	-0.10%	-3.05%	-0.91%
Total Shareholder Return	8.65%	-18.50%	1.31%	2.54%	-2.25%	-0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.